
Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Author(s) -
Dan Jones,
Suzanne KamelReid,
David W. Bahler,
H. Henry Dong,
Kojo S.J. ElenitobaJohnson,
Richard D. Press,
Neil Quigley,
Paul G. Rothberg,
Dan Sabath,
David S. Viswanatha,
Karen E. Weck,
James L. Zehnder
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5vce-p760
Subject(s) - chronic myelogenous leukemia , lymphoblastic leukemia , breakpoint cluster region , medicine , cancer research , drug resistance , leukemia , abl , oncology , immunology , biology , genetics , receptor , tyrosine kinase